JAZZ FY 2019 Earnings — Jazz Pharmaceuticals plc Revenue & Financial Results | Market Cap Arena

JAZZJazz Pharmaceuticals plc

$11B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2.2B+14.3% YoY

Gross Profit

$2.0B94.1% margin

Operating Income

$532M24.6% margin

Net Income

$523M24.2% margin

EPS (Diluted)

$9.09

Cash Flow

Operating Cash Flow

$776M

Free Cash Flow

$594M

Stock-Based Comp.

$111M

Balance Sheet

Total Assets

$5.5B

Total Liabilities

$2.4B

Stockholders' Equity

$3.1B

Cash & Equivalents

$637M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.2B	$1.9B	+14.3%
Gross Profit	$2.0B	$1.8B	+14.9%
Operating Income	$532M	$615M	-13.4%
Net Income	$523M	$447M	+17.1%